Access to safe, effective and quality-assured health products and technologies

The roadmap for WHO action 2025–2030 outlines to Member States, and other stakeholders WHO’s unique role and approach for increasing access...

Fifth WHO–UNODC Expert Consultation on New Psychoactive Substances Addressing the challenges of non‐medical use of opioids

The non‐medical use of opioids, both medicines and synthetic substances, is an increasing concern  for ...

Guidance on the WHO review of psychoactive substances for international control

In January 2010, the Executive Board of the World Health Organization's (WHO) adopted a revision of the Guidelines for The WHO Review of Psychoactive...

Left behind in pain: Extent and causes of global variations in access to morphine for medical use and actions to improve safe access

Morphine is an essential medicine for relieving moderate to severe pain. It is also essential for treating severe breathlessness that is refractory to...

WHO Expert Committee on Drug Dependence: forty-eighth report

The forty-eighth meeting of the WHO Expert Committee on Drug Dependence (ECDD) was convened from 20 to 22 October 2025 and was coordinated from WHO headquarters...